ArticleExperimental & molecular medicine2020

PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer.

Wenbin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.